Abstract:Background The costs and benefits of spliceosomal introns in eukaryotes have not been established. One recognized effect of intron splicing is its known enhancement of gene expression. However, the mechanism regulating such splicing-mediated expression enhancement has not been defined. Previous studies have shown that intron splicing is a time-consuming process, indicating that splicing may not reduce the time required for transcription and processing of spliced pre-mRNA molecules; rather, it might facilitate the later rounds of transcription. Because the densities of active RNA polymerase II on most genes are less than one molecule per gene, direct interactions between the splicing apparatus and transcriptional complexes (from the later rounds of transcription) are infrequent, and thus unlikely to account for splicing-mediated gene expression enhancement. Presentation of the hypothesis The serine/arginine-rich protein SF2/ASF can inhibit the DNA topoisomerase I activity that removes negative supercoiling of DNA generated by transcription. Consequently, splicing could make genes more receptive to RNA polymerase II during the later rounds of transcription, and thus affect the frequency of gene transcription. Compared with the transcriptional enhancement mediated by strong promoters, intron-containing genes experience a lower frequency of cut-and-paste processes. The cleavage and religation activity of DNA strands by DNA topoisomerase I was recently shown to account for transcription-associated mutagenesis. Therefore, intron-mediated enhancement of gene expression could reduce transcription-associated genome instability. Testing the hypothesis Experimentally test whether transcription-associated mutagenesis is lower in intron-containing genes than in intronless genes. Use bioinformatic analysis to check whether exons flanking lost introns have higher frequencies of short deletions. Implications of the hypothesis The mechanism of intron-mediated enhancement proposed here may also explain the positive correlation observed between intron size and gene expression levels in unicellular organisms, and the greater number of intron containing genes in higher organisms. Reviewers This article was reviewed by Dr Arcady Mushegian, Dr Igor B Rogozin (nominated by Dr I King Jordan) and Dr Alexey S Kondrashov. For the full reviews, please go to the Reviewer's Reports section.

Isoginkgetin and Madrasin are poor splicing inhibitors

Isoginkgetin and Madrasin are poor splicing inhibitors

Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A

Inhibition of SF3B1 by Molecules Targeting the Spliceosome Results in Massive Aberrant Exon Skipping

Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation

Inhibition of SF3B1 affects recruitment of P-TEFb to chromatin through multiple mechanisms

MicroRNA biogenesis is broadly disrupted by inhibition of the splicing factor SF3B1

SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion

Systematic characterization of short intronic splicing-regulatory elements in SMN2 pre-mRNA

Why Eukaryotic Cells Use Introns to Enhance Gene Expression: Splicing Reduces Transcription-Associated Mutagenesis by Inhibiting Topoisomerase I Cutting Activity

Effects of RNA Splicing Inhibitors on Amyloid Precursor Protein Expression

Systematic characterization of short intronic splicing-regulatory elements

A Molecular Brake That Modulates Spliceosome Pausing at Detained Introns Contributes to Neurodegeneration

Analysis of the Stimulatory Effect of Splicing on Mrna Production and Utilization in Mammalian Cells

Direct and indirect effects of spliceosome disruption compromise gene regulation by Nonsense-Mediated mRNA Decay

Optimization of a DNA‐launched SARS‐CoV‐2 replicon with RNA splicing inhibitor Isoginkgetin

Targeted blocking of gene splicing can dysregulate intron-embedded microRNAs

A Splicing-Independent Function of SF2/ASF in Microrna Processing.

Splice-site mutations cause Rrp6-mediated nuclear retention of the unspliced RNAs and transcriptional down-regulation of the splicing-defective genes

Smu1 and RED are required for activation of spliceosomal B complexes assembled on short introns

Experimental Tests Of Two Proofreading Mechanisms For 5 '-Splice Site Selection